Pharmagen, Inc.

Equities

PHRX

US71715W1062

Market Closed - OTC Markets Other stock markets 03:36:46 2024-05-03 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer

June 11, 2014 at 06:00 am EDT

Pharmagen, Inc. announced that Russell Skibsted has been appointed as its Executive Vice President and Chief Financial Officer. Most recently, Mr. Skibsted was Sr. Vice President, Chief Financial Officer and Secretary of Aeolus Pharmaceuticals.

Latest news about Pharmagen, Inc.

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	15-11-29	CI
Pharmagen, Inc. Announces Management Changes	14-07-02	CI
Pharmagen, Inc. Announces Executive Changes	14-06-11	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	14-06-11	CI
Pharmagen Appoints Additional Members to its Board of Directors	14-05-29	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	14-05-06	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	14-04-29	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	14-03-31	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	14-02-24	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	14-02-24	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	13-12-17	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	13-12-11	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	13-11-14	CI
Pharmagen Seeks Acquisitions	13-10-31	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	13-08-09	CI
Pharmagen, Inc. announced that it expects to receive $0.04 million in funding from Asher Enterprises, Inc.	13-08-01	CI
Pharmagen, Inc. announced that it has received $0.06 million in funding from Asher Enterprises, Inc.	13-06-19	CI
Pharmagen, Inc. announced that it expects to receive $0.06 million in funding from Asher Enterprises, Inc.	13-06-05	CI
Pharmagen, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2013	13-05-15	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Fiscal Year Ended December 31, 2012	13-04-01	CI
Pharmagen, Inc. announced that it has received $0.60 million in funding from Trafalgar Capital Advisors LTD.	13-03-29	CI
Pharmagen, Inc. announced that it expects to receive $2 million in funding from Trafalgar Capital Advisors LTD.	13-02-27	CI
Sunpeaks Ventures, Inc. will Change its Ticker to PHRX from SNPK	13-01-15	CI
Sunpeaks Ventures, Inc. Creates New Operating Unit, Pharmagen Nutraceuticals	13-01-14	CI
Sunpeaks Ventures, Inc. has Changed its Name to Pharmagen, Inc	13-01-14	CI

Chart Pharmagen, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company